-transparent.png){kind=logo}
Candida lusitaniae, a fungus with a low incidence of infection in immunocompetent people, is emerging as an opportunistic pathogen in immunocompromised hosts. This yeast is generally resistant to amphotericin B and may present therapeutic difficulties. C. lusitaniae may be misidentified as one of several other fungal species, including Candida tropicalis, Candida parapsilosis, and even Saccharomyces cerevisiae. As judged by in vitro antifungal susceptibility testing, minimal inhibitory concentrations of antifungal agents other than amphotericin B are achievable, but fungicidal levels are not. When encountered in blood or other body sites, C. lusitaniae should be carefully considered as a potential pathogen.
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
June 2007,
Archivos de la Sociedad Espanola de Oftalmologia,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
March 1998,
The Journal of rheumatology,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
March 1966,
Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
August 2019,
Acta clinica Belgica,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
July 1991,
Clinical nephrology,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
May 2009,
Journal of medical case reports,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
May 1988,
The Pediatric infectious disease journal,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
November 1993,
Postgraduate medical journal,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
January 1985,
Diagnostic microbiology and infectious disease,
T L Hadfield, and
M B Smith, and
R E Winn, and
M G Rinaldi, and
C Guerra
December 2001,
The Annals of pharmacotherapy,
